Global Clinical Stage Partnering Terms and Agreements Market Outlook 2018 – Growth Drivers, Opportunities and Forecast Analysis
Summary:
A new market study, titled “Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018 ”, has been featured on WiseGuyReports.
Report Description:
The Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals and provides details of the latest clinical agreements announced in the healthcare sector.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
Request Sample Report @ http://www.wiseguyreports.com/sample-request/3105264-global-clinical-stage-partnering-terms-and-agreements-in
This report contains a comprehensive listing of over 2,000 clinical stage partnering deals announced since 2012 including financial terms where available including numerous links to online deal records of actual clinical partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.
The report also includes numerous tables and figures that illustrate the trends and activities in clinical stage partnering and deal making since 2012.
In addition, a comprehensive appendix of all clinical stage deals since 2012 is provided organized by partnering company A-Z, deal type, therapy focus and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of clinical stage products and compounds.
Key benefits
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 provides the reader with the following key benefits:
In-depth understanding of clinical stage deal trends since 2012
Access to headline, upfront, milestone and royalty data
Analysis of the structure of clinical stage agreements with numerous real life case studies
Insight into the terms included in a clinical stage agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Report scope
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 is intended to provide the reader with an in-depth understanding and access to clinical stage deal trends and structure of deals entered into by leading companies worldwide.
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 includes:
Trends in clinical stage dealmaking in the biopharma industry since 2012
Analysis of clinical stage deal structure
Access to headline, upfront, milestone and royalty data
Case studies of real-life clinical stage deals
Access to over 2,000 clinical stage deals
The leading clinical stage deals by value since 2012
Most active clinical stage dealmakers since 2012
The leading clinical stage partnering resources
In Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018, the available contracts are listed by:
Company A-Z
Headline value
Stage of development at signing
Deal type
Specific therapy target
View Detailed Report @ https://www.wiseguyreports.com/reports/3105264-global-clinical-stage-partnering-terms-and-agreements-in
Table of Contents
Chapter 1 – Introduction
Chapter 2 – Why do companies partner clinical stage compounds?
Chapter 3 – Clinical stage deal strategies and structure
Chapter 4 – Clinical stage partnering payment strategies
Chapter 5 – Trends in clinical stage deal making
Chapter 6 – Payment terms for clinical stage partnering
Chapter 7 – Leading clinical stage deals
Chapter 8 – Top 50 most active clinical stage dealmakers
Chapter 9 – Clinical stage partnering contracts directory
Chapter 10 – Clinical stage deal making by development stage
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Monday September 10 2018, 6:58 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
